MBB SE

Share buyback: Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU)

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

MBB SE: Dr. Jakob Ammer, sell

MBB SE: Torben Teichler, sell

MBB SE: Torben Teichler, sell

MBB SE: Torben Teichler, sell

MBB SE: Dr. Ulrike Nesemeier, buy

MBB SE: Dr. Ulrike Nesemeier, buy

MBB SE: Torben Teichler, sell

MBB SE: Dr. Constantin Mang, sell

MBB SE: Dr. Constantin Mang, sell

MBB SE: Dr. Constantin Mang, sell

MBB SE: Dr. Constantin Mang, sell

MBB SE: Dr. Constantin Mang, sell

MBB SE increases EBITDA by 88% in the first nine months and raises earnings forecast again to 12% EBITDA margin

MBB SE resolves share buyback with a volume of up to €15 million and cancels treasury shares

MBB SE: Dr. Christof Nesemeier, Acquisition of shares by exercising option rights as part of the 2020 stock option program

MBB SE: MBB Capital Management GmbH , buy

MBB SE: Dr. Christof Nesemeier, sell

MBB SE: Dr. Constantin Mang, Acquisition of 18,479 shares by exercising option rights as part of the 2020 stock option program

MBB SE: Torben Teichler, Acquisition of 3,695 shares by exercising option rights as part of the 2020 stock option program

MBB SE: Torben Teichler, sell

MBB SE: Dr. Jakob Ammer, Acquisition of 3,695 shares by exercising option rights as part of the 2020 stock option program

MBB SE achieves 75% EBITDA growth in the first half-year and raises earnings forecast

MBB SE increases EBITDA by 64% to €23 million in the first quarter and achieves 11% EBITDA margin

MBB SE: Bekanntmachung der Einberufung zur Hauptversammlung am 26.06.2024 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024